Today I read an article on my iPad from the Wall Street Journal about Dexcom’s foray into Apple’s App Store, specifically an app that will display blood glucose values from their continuous glucose monitor on the soon-to-be released Apple Watch.
While the headline is all about Dexcom, the content of the article shifts somewhat dramatically to the work from the Nightscout community, and how their persistence (hence the #WeAreNotWaiting hashtag), brought the conversation about medical device use, regulatory approval, and FDA’s policies on health-related apps to the table much sooner than anyone anticipated.
After I that article, I read a blog post from Kerri about the Spare a Rose campaign. Given the knowledge that there are children with diabetes around the world without access to insulin, and a mere $5 donation means insulin and test strips for a month for a child in need – reread that first sentence.
Wall Street Journal. iPad. Dexcom. Apple Watch. When you see what kind of options we have, and compare it with the lack of opportunity others experience, the contrast in lives is quite stark.
I’m not asking you to apologize or feel guilty. I’m asking you to help make a difference. Help the Spare a Rose campaign provide insulin and test strips to children with diabetes in need.
Flowers die, but children shouldn’t. Spare a rose (from the dozen you will give your sweetheart this Valentine’s Day) and save a child with diabetes.